Latest Corporate News

Pharmascience in Canada's Top 100 Corporate R&D Spenders 2018!


GLATECT(TM) Is Now Covered by the Provincial Drug Plan in British Columbia for the Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)


Pendopharm, a division of Pharmascience Inc Wins the D.W. Bole Award

On October 10, McKesson Canada hosted its 27th edition of the 2018 Distinction Awards Gala, with the theme Customizing our solutions for the future of wellness.